BỘ KHOA HỌC VÀ CÔNG NGHỆ
HỆ THỐNG THÔNG TIN KHOA HỌC VÀ CÔNG NGHỆ

Lọc theo danh mục
  • Năm xuất bản
    Xem thêm
  • Lĩnh vực
liên kết website
Lượt truy cập
 Lượt truy cập :  23,928,259
  • Công bố khoa học và công nghệ Việt Nam

Khoa học y, dược

BB

Vũ Phương Nhung, Trần Thị Bích Ngọc(1), Nguyễn Đăng Tôn, Lê Thị Thu Hiền, Nguyễn Thùy Dương, Nông Văn Hải, Nguyễn Hải Hà*, Phạm Ngọc Thạch

Đặc điểm di truyền ở bệnh nhân Covid-19: tình hình nghiên cứu, triển vọng và thách thức trong điều trị Covid-19

Host genetic variation and Covid-19 disease: recent discoveries, prospects and challenges in the treatment of Covid-19

Tạp chí Khoa học và Công nghệ Việt Nam - B

2022

5B

40

Sự xuất hiện của virus viêm đường hô hấp cấp SARS-CoV-2 đã dẫn đến đại dịch Covid-19 trên toàn thế giới. Xác định các yếu tố nguy cơ khiến bệnh tiến triển nặng cũng như đánh giá mức độ đa dạng về tình trạng bệnh của người nhiễm SARS-CoV-2 đã trở thành một trong những mối quan tâm hàng đầu của các nhà khoa học. Các yếu tố nguy cơ đã biết bao gồm tuổi cao và bệnh nền của bệnh nhân có liên quan đến tình trạng bệnh Covid-19 tiến triển nặng. Ngoài ra, hàng loạt nghiên cứu bệnh/chứng, mô phỏng, docking, dự đoán in silico cũng như đánh giá tương quan toàn hệ gen đã được thực hiện trên nhiều quần thể người khác nhau gần đây đã đạt được một số kết quả quan trọng...

The emergence of the acute respiratory infection virus SARS-CoV-2 has spread the Covid-19 pandemic over the world. Identifying the risk factors relevant to Covid-19 clinical features, given the striking difference in the clinical symptoms observed from SARS-CoV-2 infected individuals, have become one of the primary concerns among scientists. It has been well-known that host factors such as older age and comorbidities are associated with higher severity...

Xem toàn văn
  • [1] J.L. Casanova, H.C. Su, Covid Human Genetic Effort (2020), A global effort to define the human genetics of protective immunity to SARS-CoV-2 infection,Cell
  • [2] S. Zhang, J. Wang, G. Cheng (2021), Protease cleavage of RNF20 facilitates coronavirus replication via stabilization of SREBP1,Proceedings of the National Academy of Sciences of the United States of America
  • [3] J.D. Trimarco, et al. (2021), TMEM41B is a host factor required for the replication of diverse coronaviruses including SARS-CoV-2,PLOS Pathogens
  • [4] A. Synowiec, et al. (2021), Identification of cellular factors required for SARS-CoV-2 replication,Cells
  • [5] B.N.V. Fernandez, et al. (2021), Personalized health and the coronavirus vaccines – Do individual genetics matter?,Bioessays
  • [6] B. Hu, S. Huang, L. Yin (2021), The cytokine storm and Covid-19,Journal of Medical Virology
  • [7] Y. Hou, et al. (2020), New insights into genetic susceptibility of Covid-19: an ACE2 and TMPRSS2 polymorphism analysis,BMC Medicine
  • [8] I.S. Mahmoud, et al. (2020), SARS-CoV-2 entry in host cells–multiple targets for treatment and prevention,Biochimie
  • [9] The U.S. Food and Drug Administration (2021), Fact Sheet for Health Care Providers: Emergency Use Authorization (EUA) of Remdesivir (GS-5734™),
  • [10] X.J. He, et al. (2009), Influence of ABCB1 gene polymorphisms on the pharmacokinetics of azithromycin among healthy Chinese Han ethnic subjects,Pharmacological Reports
  • [11] J.Y. Lee, et al. (2016), Association of polymorphisms of cytochrome P450 2D6 with blood hydroxychloroquine levels in patients with systemic lupus erythematosus,Arthritis & Rheumatology
  • [12] E. Maillart, et al. (2020), A case report of serious haemolysis in a glucose-6-phosphate dehydrogenase-deficient Covid-19 patient receiving hydroxychloroquine,Infectious Diseases (London)
  • [13] E.S. Rosenberg, et al. (2020), Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with Covid-19 in New York State,JAMA
  • [14] D.T. Nguyen, et al. (2021), Polymorphism of the TMPRSS2 gene relating to Covid-19 susceptibility in Vietnamese population,Academia Journal of Biology
  • [15] N.H. Nguyen, et al. (2020), The first cohort of the Covid-19 patients in Vietnam and the national response to the pandemic,International Journal of Medical Sciences
  • [16] L. Cooling (2015), Blood groups in infection and host susceptibility,Clinical Microbiology Reviews
  • [17] S.C. Wu, et al. (2021), The SARS-CoV-2 receptor-binding domain preferentially recognizes blood group A,Blood Advances
  • [18] R.L. Hoiland, et al. (2020), The association of ABO blood group with indices of disease severity and multiorgan dysfunction in Covid-19,Blood Advances
  • [19] A. Abdollahi, et al. (2020), The novel coronavirus SARS-CoV-2 vulnerability association with ABO/Rh blood types,Iranian Journal of Pathology
  • [20] E.M. Diaz, et al. (2021), Relationship between the ABO blood group and Covid-19 susceptibility, severity and mortality in two cohorts of patients,Blood Transfusion
  • [21] Y. Wu, Z. Feng, P. Li, Q. Yu (2020), Relationship between ABO blood group distribution and clinical c-haracteristics in patients with Covid-19,Clinica Chimica Acta
  • [22] S.C. Hoffmann, et al. (2002), Ethnicity greatly influences cytokine gene polymorphism distribution,American Journal of Transplantation
  • [23] J. Zuniga, et al. (2012), Genetic variants associated with severe pneumonia in A/H1N1 influenza infection,European Respiratory Journal
  • [24] C.F. Terry, V. Loukaci, F.R. Green (2000), Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation,Journal of Biological Chemistry
  • [25] S.C. Sanderson, et al. (2009), Association between IL6 gene variants -174G>C and -572G>C and serum IL-6 levels: interactions with social position in the Whitehall II cohort,Atherosclerosis
  • [26] D.J. Brull, et al. (2001), Interleukin-6 gene -174G>C and -572G>C promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery,Arteriosclerosis, Thrombosis, and Vascular Biology
  • [27] R. Minkelen, et al. (2007), Haplotypes of IL1B, IL1RN, IL1R1, and IL1R2 and the risk of venous thrombosis,Arteriosclerosis, Thrombosis, and Vascular Biology
  • [28] J.A. Patel, et al. (2006), Association of proinflammatory cytokine gene polymorphisms with susceptibility to otitis media,Pediatrics
  • [29] F. Zehsaz, et al. (2015), IL-10 G-1082A gene polymorphism and susceptibility to upper respiratory tract infection among endurance athletes,Journal of Sports Medicine and Physical Fitness
  • [30] M. Keshavarz, et al. (2019), Association of polymorphisms in inflammatory cytokines encoding genes with severe cases of influenza A/H1N1 and B in an Iranian population,Virology Journal
  • [31] W.J. Doyle, et al. (2010), The interleukin 6 -174 C/C genotype predicts greater rhinovirus illness,Journal of Infectious Diseases
  • [32] K. Revai, et al. (2009), Association between cytokine gene polymorphisms and risk for upper respiratory tract infection and acute otitis media,Clinical Infectious Diseases
  • [33] X. Chen, et al. (2020), Detectable serum severe acute respiratory syndrome coronavirus 2 viral load (RNAemia) is closely correlated with drastically elevated interleukin 6 level in critically ill patients with coronavirus disease 2019,Clinical Infectious Diseases
  • [34] Y. Tomita, T. Ikeda, R. Sato, T. Sakagami (2020), Association between HLA gene polymorphisms and mortality of Covid-19: An in silico analysis,Immunity, Inflammation and Disease
  • [35] A. Nguyen, et al. (2020), Human leukocyte antigen susceptibility map for severe acute respiratory syndrome coronavirus 2,Journal of Virology
  • [36] C.A.M.L. Porta, S. Zapperi (2020), Estimating the binding of SARS-CoV-2 peptides to HLA class I in human subpopulations using artificial neural networks,Cell Systems
  • [37] F.M.A. Naemi, et al. (2021), Association between the HLA genotype and the severity of Covid-19 infection among South Asians,Journal of Medical Virology
  • [38] D.J. Langton, et al. (2021), The influence of HLA genotype on the severity of Covid-19 infection,HLA
  • [39] A. Amoroso, et al. (2021), HLA and AB0 polymorphisms may influence SARS-CoV-2 infection and Covid-19 severity,Transplantation
  • [40] L. Lorente, et al. (2021), HLA genetic polymorphisms and prognosis of patients with Covid-19,Medicina Intensiva
  • [41] F. Wang, et al. (2020), Initial whole-genome sequencing and analysis of the host genetic contribution to Covid-19 severity and susceptibility,Cell Discovery
  • [42] A. Novelli, et al. (2020), HLA allele frequencies and susceptibility to Covid-19 in a group of 99 Italian patients,HLA
  • [43] W. Wang, et al. (2020), Distribution of HLA allele frequencies in 82 Chinese individuals with coronavirus disease-2019 (Covid-19),HLA
  • [44] J. Gao, et al. (2019), The human leukocyte antigen and genetic susceptibility in human diseases,Journal of Bio-X Research
  • [45] L.M. Zahn (2020), HLA genetics and Covid-19,Science
  • [46] A. Iwasaki, N.D. Grubaugh (2020), Why does Japan have so few cases of Covid-19?,EMBO Molecular Medicine
  • [47] Y. Shao, et al. (2016), Association study between promoter polymorphisms of ADAM17 and progression of sepsis,Cellular Physiology and Biochemistry
  • [48] Y. Li, et al. (2014), Association between ADAM17 promoter polymorphisms and ischemic stroke in a Chinese population,Journal of Atherosclerosis and Thrombosis
  • [49] L. Wulandari, et al. (2021), Initial study on TMPRSS2 p.Val160Met genetic variant in Covid-19 patients,Human Genomics
  • [50] R. Vishnubhotla, et al. (2020), Genetic variants in TMPRSS2 and structure of SARS-CoV-2 spike glycoprotein and TMPRSS2 complex,bioRxiv
  • [51] A. Paniri, M.M. Hosseini, H.A. Niaki (2021), First comprehensive computational analysis of functional consequences of TMPRSS2 SNPs in susceptibility to SARS-CoV-2 among different populations,Journal of Biomolecular Structure and Dynamics
  • [52] R. Asselta, et al. (2020), ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in Covid-19 severity in Italy,Aging (Albany NY)
  • [53] R. Russo, et al. (2020), Genetic analysis of the coronavirus SARS-CoV-2 host protease TMPRSS2 in different populations,Frontiers in Genetics
  • [54] C. Bhattac-haryya, et al. (2020), Global spread of SARS-CoV-2 subtype D614G shaped by TMPRSS2/MX1 gene regulation expression of TMPRSS2 and MX1 genes,bioRxiv
  • [55] M. Hoffmann, et al. (2020), SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2—blocked by protease inhibitor,Cell
  • [56] H. Lanjanian, et al. (2021), SARS-CoV-2 infection susceptibility influenced by ACE2 genetic polymorphisms,Scientific Reports
  • [57] M. Calcagnile, et al. (2020), ACE2 polymorphisms and susceptibility to SARS-CoV-2 infection: in silico study,bioRxiv
  • [58] E. Procko (2020), The sequence of human ACE2 is suboptimal for binding SARS-CoV-2 spike protein,bioRxiv
  • [59] K. Suryamohan, et al. (2021), Human ACE2 receptor polymorphisms and al-tered susceptibility to SARS-CoV-2,Communications Biology
  • [60] J. Chen, et al. (2020), Individual variation of ACE2 gene expression and regulation,Aging Cell
  • [61] Y. Cao, et al. (2020), Comparative genetic analysis of ACE2 in different populations,Cell Discovery
  • [62] D. Gemmati, et al. (2020), Covid-19 and individual genetic susceptibility: ACE1/ACE2 genes, immunity and coagulation,International Journal of Molecular Sciences
  • [63] W. Li, et al. (2005), Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2,The EMBO Journal
  • [64] P. Brest, et al. (2020), Host polymorphisms may impact SARS-CoV-2 infectivity,Trends in Genetics
  • [65] A. Heurich, et al. (2014), TMPRSS2 and ADAM17 cleave ACE2 differentially—only TMPRSS2 augments SARS spike entry,Journal of Virology
  • [66] N.S.A. Husn, E.E. Kenny (2019), Personalized medicine and the power of electronic health records,Cell
  • [67] A.V. Khera, et al. (2018), Genome-wide polygenic scores for common diseases and risk equivalent to monogenic mutations,Nature Genetics
  • [68] H. Namkoong, et al. (2021), Japan Covid-19 task force: host genetics of Covid-19 pandemic in Japan,medRxiv
  • [69] Covid-19 Host Genetics Initiative (2021), Mapping the human genetic architecture of Covid-19,Nature
  • [70] D. Ellinghaus, et al. (2020), Genomewide association study of severe Covid-19 with respiratory failure,New England Journal of Medicine
  • [71] P.M. Visscher, et al. (2012), Five years of GWAS discovery,American Journal of Human Genetics